Company / Operating Cash Flow per Share
Prime Medicine, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.24
FY2025
5-year range
-$4.07 / -$1.24
FY2021-FY2025
Trend
+27.0%
vs FY2024
Sector context
#122 of 212
Health Care
What the data says
At $-1.24, Prime Medicine, Inc.'s operating cash flow per share ranks #122 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-4.07 in FY2022 to $-1.24 in FY2025.
Based on SEC 10-K filings.
-1.24 in FY2025.
Improved from $-1.82 to $-1.24 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 212 in Health CareTop 58% of 212This company -$1.24 Sector average -$14.72
▼
+91.6% above sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 27.0% year-over-year.
- Ranks #122 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.24 | +27.0% |
| FY2024 | -$1.70 | +6.6% |
| FY2023 | -$1.82 | +55.3% |
| FY2022 | -$4.07 | -54.8% |
| FY2021 | -$2.63 | -25.1% |
| FY2020 | -$2.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026